Cancer remains leading focus for gene therapy innovation
Gene therapy is revolutionizing cancer treatment, offering innovative approaches to target and eradicate cancer cells at the genetic level. As of June 2024, the U.S. Food and Drug Administration (FDA) has approved several groundbreaking gene therapies, including those for various cancers, inherited eye conditions, and several blood disorders. Notably, eight of these FDA-approved gene therapies […]
Gene Therapy: Key developments and patent trends
Gene therapy offers a revolutionary approach to treating genetic disorders by introducing healthy genetic material into a patient’s cells.
Diabetes, cancer still top areas for innovation: U.S. pharmaceuticals patent landscape report
Our analysis of the U.S. pharmaceutical patent landscape in 2023 reveals that diseases like diabetes, respiratory conditions, and cancer remain at the forefront innovation. These diseases align closely with the leading causes of death reported by The US Centers for Disease Control and Prevention in 2021. Our report on the U.S. Pharmaceuticals Patent Landscape resulted […]
2023 U.S. Granted Patents: Samsung maintains patent leadership
According to our data, the USPTO granted a total of 345,344 patents in 2023 (FY 2023, spanning from October 1, 2022, to September 30, 2023). In this 2023 Patent Roundup series, we looked at patents granted by the USPTO in 2023 and analyzed the patenting trends of the top 10 assignees. Analyzing patent grants provides […]
List of 2023 US Unicorns and their patents
Only 22% of 2023 US unicorns have patents. Which companies are actively pursuing patent protection?
Patents that “shaped” the Sphere: The tech behind the multi-billion dollar Las Vegas venue
What are the patents behind Las Vegas’ Sphere? We take a closer look at MSG Entertainment’s patenting activity.
Patent Snapshot: Neuralink
In May 2023, Neuralink, the neurotech startup co-founded by Elon Musk, achieved a milestone by securing FDA approval for human trials of its brain implant, Link.
